A polymorphism (Thr17Ala) within the N-terminal signal peptide of CTLA-4 correlates with incomplete CTLA-4 glycosylation and processing at the ER, leading to lower cell surface expression and autoimmune disorders [183]. This evidence concerns the gene CTLA4 and autoimmune disease.